United States
-
Omicron Variant Underscores Need for New COVID Vaccine Candidates Like IBIO-202
– Global Reliance on Spike Protein-Based Vaccines May Create Public Health Risks – – Omicron’s Many Mutations Occur in Regions Outside Those of IBIO-202’s Nucleocapsid Antigen – – Company Expecting Feedback from U.S. FDA on…
Read More »